```html

Endometrial Bleeding: A Complete Guide

What is Endometrial Bleeding?

Endometrial bleeding refers to any abnormal bleeding that originates from the lining of the uterus (the endometrium). It can occur at times when bleeding is not expected, such as between menstrual periods, after menopause, or in response to hormonal changes. While occasional spotting can be harmless, persistent or heavy endometrial bleeding often signals an underlying medical condition that requires evaluation.

Because the uterus plays a central role in the menstrual cycle, any disruption to its hormonal regulation, structural integrity, or blood supply may manifest as irregular bleeding. Understanding the underlying cause is essential to determine whether simple lifestyle adjustments are enough or whether more intensive medical treatment is required.

Common Causes

Below are the most frequently encountered conditions that lead to endometrial bleeding. Many of these share overlapping risk factors, so a thorough assessment is crucial.

• Hormonal imbalance – Fluctuations in estrogen and progesterone (often seen in perimenopause, polycystic ovary syndrome (PCOS), or after abrupt weight changes).
• Uterine fibroids (leiomyomas) – Benign smooth‑muscle tumors that can distort the uterine cavity and cause irregular bleeding.
• Endometrial polyps – Small, benign growths on the lining that may bleed spontaneously.
• Endometrial hyperplasia – Thickening of the lining, usually due to excess estrogen, which can progress to cancer if untreated.
• Uterine (endometrial) cancer – Malignant cells in the endometrium often present with abnormal bleeding, especially after menopause.
• Adenomyosis – Endometrial tissue infiltrates the uterine muscle, leading to heavy, painful bleeding.
• Intrauterine device (IUD) – Hormonal (levonorgestrel) or copper IUDs can cause spotting, especially in the first few months.
• Pregnancy‑related issues – Implantation bleeding, ectopic pregnancy, or miscarriage can present as endometrial bleeding.
• Medications – Anticoagulants, hormonal contraceptives, or selective serotonin reuptake inhibitors (SSRIs) may alter bleeding patterns.
• Systemic conditions – Thyroid disorders, liver disease, or clotting disorders can affect the menstrual cycle.

Associated Symptoms

Endometrial bleeding often does not occur in isolation. The following symptoms may accompany it, helping clinicians narrow down the cause:

• Painful cramps or pelvic pressure
• Heavy flow that soaks a pad or tampon in < 1 hour
• Spotting between periods or after intercourse
• Bleeding after menopause (any bleeding is considered abnormal)
• Unexplained weight gain or loss
• Acne, facial hair growth, or other signs of excess androgen (common in PCOS)
• Fever, chills, or foul‑smelling vaginal discharge (suggest infection)
• Fatigue or dizziness (possible anemia from chronic blood loss)
• Pelvic mass or fullness felt during a self‑exam

When to See a Doctor

While occasional spotting can be benign, you should schedule an appointment promptly if you notice any of the following:

• Bleeding after menopause.
• Bleeding that lasts longer than 7 days or is unusually heavy.
• Pain that is severe, sudden, or worsening.
• Fever, chills, or vomiting (possible infection or miscarriage).
• Signs of anemia (fatigue, shortness of breath, pale skin).
• Bleeding after sexual intercourse.
• Known uterine fibroids or polyps that suddenly change in bleeding pattern.

Early evaluation prevents complications such as severe anemia, untreated cancer, or infertility.

Diagnosis

The diagnostic work‑up is tailored to your age, menstrual history, and risk factors. Typical steps include:

1. Detailed Medical History & Physical Exam

• Age, menstrual cycle characteristics, sexual activity, medication use, and family history of gynecologic cancers.
• Pelvic exam to assess uterine size, position, and any palpable masses.

2. Laboratory Tests

• Pregnancy test – To rule out early pregnancy or ectopic pregnancy.
• Complete blood count (CBC) – Checks for anemia.
• Thyroid‑stimulating hormone (TSH) – Screens for thyroid dysfunction.
• Coagulation profile if you take blood thinners.

3. Imaging Studies

• Transvaginal ultrasound – First‑line imaging to visualize fibroids, polyps, or thickened endometrium.
• Saline infusion sonohysterography – Improves detection of small polyps or submucosal fibroids.
• Magnetic resonance imaging (MRI) – Reserved for complex cases or when cancer is suspected.

4. Endometrial Sampling

• Office‑based endometrial biopsy or a “pipelle” sample to obtain tissue for histology.
• Hysteroscopy with directed biopsy – Allows direct visualization and removal of suspicious lesions.

Guidelines from the American College of Obstetricians and Gynecologists (ACOG) and the National Comprehensive Cancer Network (NCCN) recommend endometrial sampling for any woman over 45 with abnormal bleeding, or for younger women with risk factors (obesity, PCOS, family history of cancer) 【1】.

Treatment Options

Treatment is individualized based on cause, severity, desire for fertility, and overall health. Options fall into three broad categories:

1. Medical Management

• Hormonal therapy
  • Combined oral contraceptives – Regulate cycle and reduce endometrial proliferation.
  • Progestin‑only pills, IUDs, or oral medroxyprogesterone – Thin the endometrium, effective for hyperplasia.
  • GnRH agonists (e.g., leuprolide) – Shrink fibroids temporarily before surgery.
• Tranexamic acid – Antifibrinolytic that reduces heavy bleeding without hormonal effects.
• Non‑steroidal anti‑inflammatory drugs (NSAIDs) – Decrease menstrual blood loss by reducing prostaglandin production.
• Iron supplementation – Treats anemia from chronic blood loss.

2. Procedural / Surgical Treatments

• Office hysteroscopic polypectomy – Removes polyps without general anesthesia.
• Myomectomy – Surgical removal of fibroids while preserving the uterus (preferred for women who wish to retain fertility).
• Endometrial ablation – Destroys the uterine lining to reduce or stop bleeding; not recommended for women desiring future pregnancy.
• Hysterectomy – Definitive treatment for refractory bleeding, large fibroids, or confirmed cancer.
• Laparoscopic or robotic surgery – Minimally invasive options for adenomyosis or extensive fibroids.

3. Lifestyle & Home Care

• Maintain a healthy weight (BMI < 30) – Reduces estrogen excess from adipose tissue.
• Balanced diet rich in iron (leafy greens, legumes, lean meat) and vitamin C to enhance iron absorption.
• Avoid smoking and limit alcohol – Both can affect hormonal balance.
• Track menstrual patterns using a diary or an app to help your clinician spot trends.

Prevention Tips

While not all causes are preventable, several strategies can lower the risk of abnormal endometrial bleeding:

• Weight management – Obesity is a strong risk factor for estrogen‑driven hyperplasia and cancer.
• Regular physical activity – Improves insulin sensitivity and hormone regulation.
• Routine gynecologic exams – Early detection of polyps, fibroids, or precancerous changes.
• Safe use of hormonal contraception – Follow prescribing guidelines; discuss alternatives if you experience persistent spotting.
• Limit exposure to endocrine disruptors – Reduce use of plastics containing BPA, avoid excessive soy supplements, and read medication labels.
• Manage chronic conditions – Keep thyroid disease, diabetes, and clotting disorders well‑controlled.

Emergency Warning Signs

Key Takeaways

Endometrial bleeding is a symptom with a broad differential—from benign hormonal shifts to serious conditions like endometrial cancer. Prompt evaluation, especially for women over 45 or those with risk factors, is essential. A combination of history, physical exam, imaging, and tissue sampling usually identifies the cause, allowing tailored medical or surgical treatment. Maintaining a healthy lifestyle, staying up‑to‑date with gynecologic screenings, and knowing the red‑flag signs can greatly reduce complications.

References

• American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 211: Management of Abnormal Uterine Bleeding. 2023.
• National Comprehensive Cancer Network. Uterine Neoplasms Guidelines. Version 2.2026.
• Mayo Clinic. “Abnormal uterine bleeding.” Updated March 2024.
• Cleveland Clinic. “Endometrial hyperplasia and cancer.” Accessed May 2026.
• World Health Organization. International Classification of Diseases (ICD‑11) – Codes for Gynecologic Disorders. 2024.

```